Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

KGC

Kinross Gold Corp.

Apr 24 • 04:00PM ET

6.60

Dollar change +0.04
Percentage change 0.61	%

Basic Materials • Gold • Canada • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: GDX GDXJ DFIV DFIC DFAX DFAI DIHP IGE CVY PXF

Index	-	P/E	19.60	EPS (ttm)	0.34	Insider Own	0.86%	Shs Outstand	1.23B	Perf Week	2.80%
Market Cap	8.11B	Forward P/E	13.47	EPS next Y	0.49	Insider Trans	0.00%	Shs Float	1.22B	Perf Month	15.99%
Income	416.30M	PEG	-	EPS next Q	0.06	Inst Own	59.99%	Short Float	0.98%	Perf Quarter	21.77%
Sales	4.24B	P/S	1.91	EPS this Y	-2.49%	Inst Trans	46.40%	Short Ratio	0.79	Perf Half Y	23.13%
Book/sh	4.95	P/B	1.33	EPS next Y	14.21%	ROA	3.98%	Short Interest	11.90M	Perf Year	31.47%
Cash/sh	0.29	P/C	22.39	EPS next 5Y	-	ROE	6.99%	52W Range	4.32 - 6.82	Perf YTD	9.09%
Dividend Est.	0.12 (1.82%)	P/FCF	23.88	EPS past 5Y	-	ROI	5.00%	52W High	-3.15%	Beta	1.14
Dividend TTM	0.12 (1.82%)	Quick Ratio	0.79	Sales past 5Y	9.33%	Gross Margin	22.11%	52W Low	52.78%	ATR (14)	0.23
Dividend Ex-Date	Mar 05, 2024	Current Ratio	2.47	EPS Y/Y TTM	170.38%	Oper. Margin	18.12%	RSI (14)	62.70	Volatility	3.25% 3.41%
Employees	-	Debt/Eq	0.37	Sales Y/Y TTM	20.37%	Profit Margin	9.82%	Recom	2.05	Target Price	7.97
Option/Short	Yes / Yes	LT Debt/Eq	0.37	EPS Q/Q	161.48%	Payout	35.55%	Rel Volume	0.80	Prev Close	6.56
Sales Surprise	6.89%	EPS Surprise	13.52%	Sales Q/Q	3.67%	Earnings	Feb 14 AMC	Avg Volume	15.06M	Price	6.60
SMA20	4.12%	SMA50	15.63%	SMA200	22.74%	Trades		Volume	12,086,870	Change	0.61%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-29-24	Resumed	Jefferies	Hold	$5.50 → $5
Sep-12-23	Initiated	Desjardins	Buy
Apr-05-23	Downgrade	BofA Securities	Buy → Underperform	$4.70
Jan-30-23	Downgrade	Barclays	Overweight → Equal Weight
Apr-20-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$6
Mar-03-22	Downgrade	Credit Suisse	Outperform → Neutral	$7 → $5.25
Jul-30-21	Upgrade	National Bank Financial	Sector Perform → Outperform
Jun-23-21	Upgrade	Credit Suisse	Neutral → Outperform	$7.50 → $8
Jun-22-21	Downgrade	National Bank Financial	Outperform → Sector Perform
Jun-22-21	Downgrade	CIBC	Sector Outperform → Neutral	$11.25 → $8.50
Feb-10-21	Resumed	JP Morgan	Overweight
Jan-06-21	Upgrade	Barclays	Equal Weight → Overweight	$9
Aug-05-20	Upgrade	BofA Securities	Neutral → Buy	$11.25
Jun-16-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$7 → $7.50
Apr-16-20	Upgrade	Scotiabank	Sector Perform → Sector Outperform
Jan-23-20	Resumed	Credit Suisse	Neutral
Dec-05-19	Resumed	RBC Capital Mkts	Sector Perform
Oct-15-19	Downgrade	Barclays	Overweight → Equal Weight
May-30-19	Downgrade	JP Morgan	Neutral → Underweight
Dec-19-18	Downgrade	Credit Suisse	Neutral → Underperform

Show Previous Ratings

Apr-23-24 09:12AM	3 High Yield Dividend Stocks You Can Buy For Under $10 (Benzinga)
Apr-22-24 12:10PM	Will Kinross Gold (KGC) Beat Estimates Again in Its Next Earnings Report? (Zacks)
11:22AM	AbraSilver Resource's Outperform Rating, $0.90 Price Target, Maintained by National Bank of Canada (MT Newswires)
07:30AM	AbraSilver Announces C$20 Million in Strategic Investments by Kinross Gold and Central Puerto and Formation of a Regional Partnership in Argentina (PR Newswire)
Apr-10-24 01:57PM	Bullion Bullseye: 3 Gold Stocks for Precious Metal Profits (InvestorPlace)
05:00PM	Loading…
Apr-09-24 05:00PM	Kinross to announce Q1 results on May 7, 2024 (GlobeNewswire)
10:48AM	Gilded Gains: 3 Gold Stocks to Shine in Your Portfolio (InvestorPlace)
Apr-08-24 04:02PM	3 Stock Trades to Make for 50% Returns in Q2 2024 (InvestorPlace)
Apr-04-24 08:51AM	7 Under-$10 Stocks to Buy for 5-Bagger Returns in 5 Years (InvestorPlace)
Apr-03-24 10:00AM	Kinross Gold Is Betting on the Great Bear Project (GuruFocus.com)
Apr-02-24 06:40AM	3 Undervalued Growth Stocks That Also Offer Attractive Dividends: April 2024 (InvestorPlace)
Mar-24-24 08:10AM	13 Most Profitable Gold Stocks To Invest In (Insider Monkey)
Mar-22-24 06:32PM	3 Gold Mining Stocks That Could Strike It Rich for Investors in 2024 (InvestorPlace)
Mar-18-24 03:15PM	Hot Stocks: The 3 Best Opportunities for Investing in Gold (InvestorPlace)
07:26AM	Analyst Report: Kinross Gold Corporation (Morningstar Research)
05:27PM	Loading…
Mar-15-24 05:27PM	12 Biggest Canadian Mining Companies (Insider Monkey)
11:30AM	Kinross Gold (KGC) Up 9.8% Since Last Earnings Report: Can It Continue? (Zacks)
Mar-13-24 03:35PM	The 3 Most Undervalued Stocks to Buy for Under $10 in March 2024 (InvestorPlace)
Mar-11-24 03:26PM	Multibagger Mania: 3 Stocks That Could Multiply Your Money (InvestorPlace)
Mar-06-24 01:30PM	Next-Gen Gold Rush: 3 Mining Stocks That Are Pure Gold (InvestorPlace)
Mar-03-24 11:33PM	12 Best Single Digit Stocks To Invest In (Insider Monkey)
Mar-02-24 08:39AM	3 Gold Miners Glittering With Potential in 2024 (InvestorPlace)
Feb-26-24 06:15PM	The 3 Best Dividend Stocks Under $10 to Buy Now (InvestorPlace)
01:14PM	12 $10 Stocks That Will Triple (Insider Monkey)
Feb-23-24 10:48AM	12 Best Gold Stocks Under $25 (Insider Monkey)
Feb-22-24 07:00AM	White Gold Corp. Discovers 1 km Long Gold-In-Soil Anomaly 9 km Northwest of Its VG Deposit, White Gold District, Yukon, Canada (GlobeNewswire)
Feb-21-24 03:08PM	3 Undervalued Growth Stocks to Buy for 3x Returns By 2025 (InvestorPlace)
Feb-20-24 02:15PM	12 Best Gold Mining Companies to Invest In According to Analysts (Insider Monkey)
Feb-18-24 07:08PM	Analyst Report: Kinross Gold Corporation (Morningstar Research)
Feb-16-24 11:22AM	Kinross Gold Corporation (NYSE:KGC) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:00AM	Loading…
Feb-15-24 07:00AM	Kinross' (KGC) Earnings and Sales Surpass Estimates in Q4 (Zacks)
Feb-14-24 06:30PM	Kinross Gold (KGC) Q4 Earnings and Revenues Beat Estimates (Zacks)
05:38PM	Kinross Gold: Q4 Earnings Snapshot (Associated Press Finance)
05:07PM	Kinross declares quarterly dividend (GlobeNewswire)
05:06PM	Kinross reports 2023 fourth-quarter and full-year results (GlobeNewswire)
Feb-13-24 08:48AM	Should You Buy Kinross (KGC) Ahead of Earnings? (Zacks)
Feb-07-24 10:00AM	Kinross Gold (KGC) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-01-24 06:42PM	3 Strong Buy Stocks Under $10: January 2024 (InvestorPlace)
Jan-30-24 08:30AM	As Today's Global Market Fluctuates with Uncertainty, Some Analysts Forecasting Upside in Times Ahead for Gold (GlobeNewswire)
Jan-25-24 09:40AM	Here's Why Kinross Gold (KGC) is a Strong Value Stock (Zacks)
Jan-18-24 12:10PM	Will Kinross Gold (KGC) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-17-24 10:47AM	The 3 Best Dividend Growth Stocks to Buy in January 2024 (InvestorPlace)
Jan-16-24 02:43PM	2024s Gold Rush: 3 Mining Stocks With Massive Upside Potential (InvestorPlace)
Jan-15-24 11:21PM	Analyst Report: Kinross Gold Corporation (Morningstar Research)
05:00PM	Kinross to announce 2023 Q4/full-year results and 2024 guidance on February 14, 2024 (GlobeNewswire)
Jan-13-24 11:39PM	3 Precious Metals Stocks That Will Shine in 2024 (InvestorPlace)
Jan-09-24 06:21PM	Why Kinross Gold (KGC) is a Top Value Stock for the Long-Term (Zacks)
Jan-02-24 08:42AM	3 Stocks Under $10 That Will Be 3-Baggers by 2025 (InvestorPlace)
Dec-28-23 04:51PM	Growth Galore: 7 Long-Term Stock Picks for Prolonged Prosperity (InvestorPlace)
Dec-23-23 07:37PM	13 Best Mining Stocks To Buy Now (Insider Monkey)
Dec-20-23 06:04PM	3 Stocks Under $10 That Can Triple in 2024 (InvestorPlace)
Dec-18-23 08:41AM	Analyst Report: Kinross Gold Corporation (Morningstar Research)
Dec-08-23 11:30AM	Why Is Kinross Gold (KGC) Up 8% Since Last Earnings Report? (Zacks)
Dec-06-23 04:05PM	12 Best Gold Dividend Stocks To Buy Now (Insider Monkey)
Dec-05-23 09:48AM	20 Countries With The Highest Inflation in 2023 (Insider Monkey)
Dec-04-23 09:31AM	Affordable Allstars: 3 Stocks Under $10 That Can Double in 2024 (InvestorPlace)
Nov-30-23 07:45AM	12 Best Mineral Stocks To Buy Now (Insider Monkey)
Nov-29-23 07:28AM	3 Stocks Under $10 Offering a Robust Dividend Yield (InvestorPlace)
03:19AM	12 Most Undervalued Gold Stocks To Buy According To Hedge Funds (Insider Monkey)
Nov-22-23 07:26AM	3 Hot Penny Stocks Due to Double in 2024 (InvestorPlace)
Nov-20-23 09:20AM	7 Cheap Stocks to Buy Now if You Have $100 to Spend: November Edition (InvestorPlace)
09:03AM	7 Value Penny Stocks to Multiply Your Investment (InvestorPlace)
Nov-14-23 06:30AM	White Gold Corp. Intercepts 5.04 g/t Au over 20.85m in Western Extension of Near Surface High-Grade Gold Zone & Identifies Additional Gold Occurrences in the Sulphide Domain at Betty Ford Target, White Gold District, Yukon, Canada (GlobeNewswire)
Nov-13-23 05:59PM	11 Best Canadian Gold Stocks To Buy Now (Insider Monkey)
Nov-10-23 11:27AM	Kinross Gold Corporation (NYSE:KGC) Q3 2023 Earnings Call Transcript (Insider Monkey)
06:27AM	Kinross' (KGC) Q3 Earnings and Revenues Outpace Estimates (Zacks)
Nov-09-23 11:06PM	Analyst Report: Kinross Gold Corporation (Morningstar Research)
02:19PM	Top 20 Gold Mining Companies in the World (Insider Monkey)
07:45AM	3 Stocks to Buy as Gold Touches $2,000 an Ounce (InvestorPlace)
Nov-08-23 06:13PM	Kinross Gold: Q3 Earnings Snapshot (Associated Press Finance)
05:00PM	Kinross reports strong 2023 third-quarter results (GlobeNewswire)
05:00PM	Kinross declares quarterly dividend (GlobeNewswire)
08:37AM	3 Growth Stocks That Will Blast Higher in 2024 (InvestorPlace)
07:00AM	White Gold Corp. Intersects 5.03 g/t Gold over 25.0m within 2.96 g/t Gold over 46.5m Significantly Expanding Width of Near Surface Gold Zone by 50% at Betty Ford Target, White Gold District, Yukon, Canada (GlobeNewswire)
Nov-03-23 12:00PM	Denison Mine (DNN) to Report Q3 Earnings: What's in Store? (Zacks)
Nov-02-23 07:59AM	Air Products (APD) to Report Q4 Earnings: What's in the Offing? (Zacks)
07:15AM	Barrick Gold (GOLD) Beats Q3 Earnings Estimates (Zacks)
Nov-01-23 10:15PM	Gold Rush 2023: 3 Mining Stocks Ready to Shine Brighter Than Ever (InvestorPlace)
10:01AM	Kinross Gold (KGC) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
07:20AM	Celanese (CE) to Report Q3 Earnings: What's in the Offing? (Zacks)
Oct-30-23 12:02PM	Energy Fuels (UUUU) to Post Q3 Earnings: What's in Store? (Zacks)
09:13AM	DuPont (DD) Gears Up for Q3 Earnings: What's in the Cards? (Zacks)
09:13AM	Albemarle (ALB) to Post Q3 Earnings: What's in the Offing? (Zacks)
Oct-27-23 12:07PM	Alpha Metallurgical (AMR) to Post Q3 Earnings: What's in Store? (Zacks)
07:05AM	Livent (LTHM) to Report Q3 Earnings: What's in the Offing? (Zacks)
Oct-26-23 06:55PM	Comstock Inc. (LODE) Q3 Earnings Top Estimates (Zacks)
Oct-24-23 10:37AM	International Paper (IP) to Post Q3 Earnings: What's in Store? (Zacks)
Oct-23-23 07:30PM	3 Under-$10 Stocks That Can Double Next Year (InvestorPlace)
10:00AM	Best Momentum Stocks to Buy for October 23rd (Zacks)
09:40AM	Is Denison Mine Corp (DNN) Stock Outpacing Its Basic Materials Peers This Year? (Zacks)
09:40AM	How to Find Strong Buy Basic Materials Stocks Using the Zacks Rank (Zacks)
Oct-20-23 12:45PM	Here is Why Growth Investors Should Buy Kinross Gold (KGC) Now (Zacks)
05:32AM	7 Penny Stocks With the Potential to Strike Gold (InvestorPlace)
05:25AM	Newmont (NEM) to Report Q3 Earnings: What's in the Offing? (Zacks)
Oct-19-23 09:50AM	Here's Why Kinross Gold (KGC) is a Strong Momentum Stock (Zacks)
08:56AM	Dow (DOW) Warms Up to Q3 Earnings: What's in the Cards? (Zacks)
Oct-18-23 06:48AM	Will Weaker Steel Prices Dent Nucor's (NUE) Earnings in Q3? (Zacks)
Oct-17-23 01:08PM	Cameco Corp (CCJ) to Report Q3 Earnings: What to Expect (Zacks)
07:57AM	Freeport (FCX) to Report Q3 Earnings: What's in the Offing? (Zacks)
07:56AM	Cleveland-Cliffs (CLF) to Report Q3 Earnings: What's in Store? (Zacks)

Kinross Gold Corp. engages in the production, acquisition, exploration, and development of gold properties. Its mining operations are in the United States, the Russian Federation, Brazil, Chile, Ghana, and Mauritania. The firm operates through the following business segments: Fort Knox, Round Mountain, Bald Mountain, Kupol, Paracatu, Tasiast, Chirano, and Corporate & Other. The Kupol segment consists of the Kupol and Dvoinoye mines. The Corporate & Other segment includes corporate, shutdown, and other non-operating assets and non-mining, and other operations. The company was founded by Robert MacKay Buchan on May 31, 1993 and is headquartered in Toronto, Canada.

Dollar change 0.00
Percentage change 0.00	%

TEVA Teva- Pharmaceutical Industries Ltd. ADR daily Stock Chart

Index	-	P/E	-	EPS (ttm)	-0.48	Insider Own	0.01%	Shs Outstand	1.12B	Perf Week	-1.29%
Market Cap	14.58B	Forward P/E	4.94	EPS next Y	2.63	Insider Trans	-85.80%	Shs Float	1.12B	Perf Month	-7.47%
Income	-527.00M	PEG	-	EPS next Q	0.51	Inst Own	52.49%	Short Float	1.03%	Perf Quarter	8.69%
Sales	15.84B	P/S	0.92	EPS this Y	-6.18%	Inst Trans	8.94%	Short Ratio	1.13	Perf Half Y	59.05%
Book/sh	6.70	P/B	1.94	EPS next Y	9.69%	ROA	-1.20%	Short Interest	11.56M	Perf Year	55.81%
Cash/sh	2.88	P/C	4.52	EPS next 5Y	1.60%	ROE	-6.84%	52W Range	7.09 - 14.47	Perf YTD	24.62%
Dividend Est.	-	P/FCF	6.29	EPS past 5Y	26.63%	ROI	-2.03%	52W High	-10.06%	Beta	1.07
Dividend TTM	-	Quick Ratio	0.69	Sales past 5Y	-2.68%	Gross Margin	48.24%	52W Low	83.63%	ATR (14)	0.35
Dividend Ex-Date	Nov 27, 2017	Current Ratio	1.02	EPS Y/Y TTM	77.75%	Oper. Margin	20.15%	RSI (14)	40.66	Volatility	2.72% 2.55%
Employees	37226	Debt/Eq	2.70	Sales Y/Y TTM	6.11%	Profit Margin	-3.33%	Recom	2.07	Target Price	16.12
Option/Short	Yes / Yes	LT Debt/Eq	2.46	EPS Q/Q	136.88%	Payout	-	Rel Volume	0.73	Prev Close	13.01
Sales Surprise	10.69%	EPS Surprise	30.29%	Sales Q/Q	13.62%	Earnings	May 08 BMO	Avg Volume	10.21M	Price	13.01
SMA20	-4.68%	SMA50	-3.44%	SMA200	21.40%	Trades		Volume	7,477,528	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-08-24	Upgrade	JP Morgan	Underweight → Neutral	$14
Feb-12-24	Upgrade	Piper Sandler	Neutral → Overweight	$12 → $19
Jan-23-24	Upgrade	Jefferies	Hold → Buy	$10 → $14
Jan-03-24	Upgrade	Piper Sandler	Underweight → Neutral	$8 → $12
Dec-18-23	Initiated	HSBC Securities	Buy	$13
Nov-27-23	Upgrade	UBS	Neutral → Buy	$11 → $13
Jul-06-23	Upgrade	UBS	Sell → Neutral	$7 → $8
May-25-23	Initiated	Morgan Stanley	Equal-Weight	$10
May-18-23	Upgrade	Evercore ISI	In-line → Outperform
Jan-19-23	Downgrade	Jefferies	Buy → Hold	$10 → $12
Nov-14-22	Downgrade	JP Morgan	Neutral → Underweight	$11 → $10
Nov-04-22	Downgrade	UBS	Neutral → Sell
Oct-21-22	Resumed	Jefferies	Buy	$10
Aug-05-22	Upgrade	BofA Securities	Neutral → Buy	$10 → $13
Jun-14-22	Resumed	UBS	Neutral	$10
May-17-22	Upgrade	BofA Securities	Underperform → Neutral	$9
May-04-22	Downgrade	Piper Sandler	Neutral → Underweight	$11 → $7
Apr-05-22	Upgrade	Barclays	Equal Weight → Overweight	$11 → $13
Mar-25-22	Upgrade	Bernstein	Mkt Perform → Outperform	$11
Jan-27-22	Downgrade	Argus	Buy → Hold

Show Previous Ratings

Apr-22-24 11:37AM	UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents (Reuters)
Apr-21-24 10:39AM	11 Best Low Price Pharma Stocks To Invest In (Insider Monkey)
Apr-16-24 05:43PM	Alvotech and Teva Announce U.S. FDA Approval of SELARSDI (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab) (Business Wire)
08:00AM	Tevas New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets (Business Wire)
Apr-15-24 05:21PM	Israeli economy has proven to thrive despite crisis: Expert (Yahoo Finance Video)
08:30AM	Loading…
Apr-11-24 08:30AM	Teva Confirms Efficacy and Safety of AJOVY® (fremanezumab) for the Prevention of Migraine With Results from Phase 3 Trial in China (Business Wire)
Apr-09-24 04:30PM	Teva to Host Conference Call to Discuss First Quarter 2024 Financial Results at 8 a.m. ET on May 8, 2024 (Business Wire)
Apr-06-24 01:00PM	New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024 (Business Wire)
Apr-04-24 08:30AM	Teva and mAbxience Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate (Business Wire)
Apr-03-24 05:21AM	3 No-Brainer Stocks to Buy With $600 Right Now (Motley Fool)
05:00AM	Biden and Senator Sanders to highlight efforts lower cost of asthma inhalers (Reuters)
Apr-01-24 02:01PM	UPDATE 1-Teva, Viatris win new chance to challenge J&J schizophrenia drug patent (Reuters)
11:52AM	Teva, Viatris win new chance to challenge J&J schizophrenia drug patent (Reuters)
08:30AM	Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement (Business Wire)
Mar-24-24 07:30PM	25 Countries with the Lowest Fertility Rates (Insider Monkey)
11:10PM	Loading…
Mar-21-24 11:10PM	Q4 2023 Alvotech SA Earnings Call (Thomson Reuters StreetEvents)
Mar-18-24 03:06PM	Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow? (The Wall Street Journal)
Mar-08-24 05:00AM	EVP, CFO Eliyahu Kalif Sells 77,550 Shares of Teva Pharmaceutical Industries Ltd (TEVA) (GuruFocus.com)
Feb-26-24 02:19PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
09:58AM	TEVA Stock Pops 4% as Teva Receives FDA Approval (InvestorPlace)
07:00AM	Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China (Business Wire)
Feb-23-24 08:15PM	Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira® (Business Wire)
Feb-20-24 08:30AM	Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-574) Antibody at the 2024 ECCO Annual Meeting (Business Wire)
04:43AM	UPDATE 2-Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO (Reuters)
04:00AM	Teva Pharm to stay as unified generics, branded drugmaker -CEO says (Reuters)
Feb-16-24 09:04AM	Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:57AM	Q4 2023 Corcept Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-13-24 12:08AM	Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight (GuruFocus.com)
Feb-12-24 10:18AM	Teva Pharmaceutical upgraded at Piper Sandler (Yahoo Finance Video) +7.49%
Feb-09-24 05:02PM	David Abrams Adjusts Portfolio, Meta Platforms Sees Notable Reduction (GuruFocus.com)
09:02AM	Loading…
Feb-05-24 09:02AM	Chief Accounting Officer Amir Weiss Sells 31,766 Shares of Teva Pharmaceutical Industries Ltd (GuruFocus.com)
Feb-01-24 11:42AM	Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Jan-31-24 04:05PM	Teva, GSK Put Up Bullish Fourth-Quarter Performances. Here's Where Novartis Fell Short. (Investor's Business Daily)
03:51PM	Teva Plans to Divest Drug Ingredients Business in Next Step of Strategic Shift (Barrons.com)
02:55PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
01:30PM	Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript (Motley Fool)
01:07PM	How Teva's CEO is implementing his 'pivot to growth' strategy (Yahoo Finance Video)
10:30AM	Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
10:20AM	UPDATE 1-Teva Pharm sees lower 2024 profit after large Q4 beat (Reuters)
09:09AM	Teva Sinks On Lackluster Profit Outlook Despite Walloping Quarterly Projections (Investor's Business Daily)
08:10AM	Teva Pharma sees lower 2024 profit but higher sales after large Q4 beat (Reuters)
07:52AM	Teva Pharmaceutical Industries Ltd (TEVA) Reports Solid Growth in 2023 Earnings (GuruFocus.com)
07:20AM	Teva Pharma Guides FY24 Revenue Above Estimates; Intends To Divest API Business - Update (RTT News)
07:00AM	Teva Reports Growth in Fourth Quarter and Full Year 2023 (Business Wire)
06:32AM	Teva to divest active pharmaceutical ingredient business (Reuters)
06:20AM	UPDATE 2-Teva to divest active pharmaceutical ingredient business (Reuters)
06:00AM	Teva Announces Intention to Divest API Business as Part of Pivot to Growth Strategy (Business Wire)
Jan-28-24 12:42PM	50 Most Populated Countries in the World in 2024 (Insider Monkey)
Jan-26-24 09:15AM	Unveiling Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Jan-25-24 09:40AM	Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now? (Zacks)
Jan-23-24 01:43AM	ExxonMobil, Duke Energy raised on improving sector valuations: 4 big analyst picks (Investing.com)
Jan-12-24 09:00AM	Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space (Investor's Business Daily)
Jan-10-24 05:21AM	3 No-Brainer Stocks to Buy With $20 Right Now (Motley Fool)
Jan-02-24 04:30PM	Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024 (Business Wire)
Dec-29-23 06:43PM	Corcept loses patent spat against Teva, shares tumble (Reuters)
06:34PM	UPDATE 2-Corcept loses patent spat against Teva, shares tumble (Reuters)
06:14PM	US judge rules in favor of Teva over patent spat with Corcept (Reuters)
Dec-28-23 04:30PM	Teva to Present at the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-26-23 10:51AM	HSBC Sees Opportunity in These 2 Biopharma Giants Ahead of the 2024 Elections (TipRanks)
Dec-22-23 10:54AM	GSK, Amneal, Kaléo delist patents from FDA's orange book (Yahoo Finance Video)
Dec-21-23 05:45AM	Here's Why Teva Pharmaceutical Industries Limited (TEVA) Rose in Q3 (Insider Monkey)
Dec-15-23 05:21AM	My 5 Largest Portfolio Holdings for 2024 (Motley Fool)
Dec-14-23 08:30AM	Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma (Business Wire)
Dec-07-23 02:03PM	FTC warns pharma companies on excessive drug patenting (Yahoo Finance Video)
Dec-06-23 02:00AM	New Post Hoc Phase 3 Data Analysis Shows AJOVY® (fremanezumab) Reduced Migraine Attacks in Adults with Migraine and Co-morbid Obesity (Business Wire)
Nov-30-23 08:30AM	Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment (Business Wire)
Nov-27-23 10:14AM	Teva Pharmaceutical upgraded to 'Buy' at UBS (Yahoo Finance Video)
09:56AM	Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls (The Fly)
09:37AM	Teva Pharmaceutical: Long-Term Cash Cow (GuruFocus.com)
08:15AM	Midday movers: Affirm, Amazon, and More (Investing.com)
01:50AM	Roku raised to Buy, YPF extends gains following upgrade: 4 big analyst picks (Investing.com)
Nov-24-23 08:16PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
Nov-20-23 04:30PM	Teva to Present at the 6th Annual Evercore ISI HealthCONx Conference (Business Wire)
Nov-17-23 08:30AM	Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S. (Business Wire)
Nov-15-23 07:03PM	50 Most Populated Countries in 2030 (Insider Monkey)
Nov-13-23 08:10AM	Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program (GlobeNewswire)
08:00AM	Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program (Business Wire)
Nov-12-23 12:02AM	Decoding Teva Pharmaceutical Industries Ltd (TEVA): A Strategic SWOT Insight (GuruFocus.com)
Nov-09-23 01:21PM	Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 04:31PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
04:01PM	Teva Pharma Makes A Bullish Move After Quarterly Beat, Business Separation Plans (Investor's Business Daily)
03:05PM	Teva Pharmaceutical Industries Ltd (TEVA) Reports Q3 2023 Earnings and Raises Revenue Outlook (GuruFocus.com)
02:15PM	Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Call Transcript (Motley Fool)
01:22PM	Israels Teva Lifts Outlook With War Not Curbing Drug Production (Bloomberg)
12:05PM	Teva Pharmaceutical Nears Breakout On Quarterly Beat, Business Separation (Investor's Business Daily)
09:30AM	Teva Pharmaceutical Industries Ltd. (TEVA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:01AM	Teva Closes In On A Buy Point On Third-Quarter Beat, Business Separation (Investor's Business Daily)
08:04AM	UPDATE 3-Teva says Israel-Hamas war not hurting production, eyes growth in 2024 (Reuters)
07:40AM	Teva says Israel-Hamas war not hurting production, eyes growth in 2024 (Reuters)
07:37AM	Teva Pharm Q3 profit rises, sees higher 2023 revenue (Reuters)
07:27AM	Teva Pharma Boosts FY23 Revenue Outlook - Update (RTT News)
07:00AM	Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance (Business Wire)
Nov-07-23 04:30PM	Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business (Business Wire)
Nov-02-23 11:23AM	Exelixis (EXEL) Q3 Earnings and Sales Miss, Annual View Updated (Zacks)
08:00AM	Teva to Present New Data Supporting Safety, Efficacy and Real-World Effectiveness of AUSTEDO® (deutetrabenazine) Tablets at the 2023 HSG Annual Meeting (Business Wire)
Nov-01-23 07:31PM	UZEDY (risperidone) Extended-Release Injectable Suspension Significantly Prolongs Time to Schizophrenia Relapse in RISE Study Results Published in The Lancet Psychiatry (Business Wire)
Oct-30-23 04:35PM	13 Most Undervalued Pharma Stocks To Buy According To Analysts (Insider Monkey) +5.30%
Oct-25-23 09:00AM	Teva to Provide Second Round of Funding to Clinics in California, Florida and New Jersey as Part of $2 Million Commitment Through Community Routes: Access to Mental Health Care Program (Business Wire)
Oct-18-23 04:56AM	Israeli drugmaker Teva loses appeal against EU fine -EU court ruling (Reuters)
Oct-17-23 01:30AM	Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder (Business Wire)

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Mar 06 '24	Sale	13.52	77,550	1,048,119	203,691	Mar 07 04:27 PM
Sabag Mark	EVP, International Markets	Mar 05 '24	Sale	13.52	100,000	1,352,090	382,590	Mar 07 04:12 PM
Daniell Richard	Exec. VP, European Commercial	Mar 05 '24	Sale	13.52	48,629	657,240	69,770	Mar 07 04:20 PM
Conway Vikki L	See "Remarks"	Mar 05 '24	Sale	13.52	1,427	19,286	15,219	Mar 07 04:16 PM
Daniell Richard	Exec. VP, European Commercial	Mar 04 '24	Sale	13.34	95,762	1,277,207	69,770	Mar 05 04:21 PM
Francis Richard D	President and CEO	Mar 04 '24	Sale	13.34	31,061	414,270	123,295	Mar 05 04:27 PM
Hughes Eric A	See "Remarks"	Mar 04 '24	Sale	13.34	8,045	107,299	16,855	Mar 05 04:16 PM
Conway Vikki L	See "Remarks"	Mar 04 '24	Sale	13.37	3,532	47,234	6,617	Mar 05 04:39 PM
Daniell Richard	Exec. VP, European Commercial	Feb 28 '24	Sale	13.12	20,599	270,176	69,770	Mar 01 06:43 AM
Drape Eric	Executive VP Global Operations	Feb 28 '24	Sale	13.12	9,815	128,734	9,701	Mar 01 06:45 AM
Conway Vikki L	See "Remarks"	Feb 28 '24	Sale	13.12	1,366	17,916	2,928	Mar 01 06:40 AM
Drape Eric	Executive VP Global Operations	Feb 16 '24	Sale	13.05	173,261	2,261,905	1	Feb 21 07:37 AM
Francis Richard D	President and CEO	Feb 15 '24	Sale	13.15	74,530	980,174	87,125	Feb 20 07:42 AM
Weiss Amir	Chief Accounting Officer	Feb 01 '24	Sale	12.37	31,766	392,955	10,676	Feb 05 07:49 AM
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Aug 07 '23	Sale	9.73	35,125	341,889	99,162	Aug 09 04:02 PM
Weiss Amir	Chief Accounting Officer	Aug 04 '23	Sale	9.92	1,981	19,658	42,442	Aug 07 04:15 PM
Hughes Eric A	See "Remarks"	Aug 01 '23	Sale	8.30	52,742	437,690	0	Aug 03 07:09 AM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

KGC

Kinross Gold Corp.

TEVA

Teva- Pharmaceutical Industries Ltd. ADR

Upgrade your FINVIZ experience